FLC
BHVN

Fifth Lane Capital’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Fifth Lane Capital’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-140,000
Closed -$21.2M – 271
2022
Q3 		$21.2M Buy
+140,000
New +$21.2M 11.03% 4